Skip to main content
Top
Published in: Journal of Inflammation 1/2013

Open Access 01-12-2013 | Research

Abdominal adiposity is the main determinant of the C-reactive response to injury in subjects undergoing inguinal hernia repair

Authors: Sashidhar Irkulla, Bedri Ujam, David Gaze, Devinder Kumar, Michael A Mendall

Published in: Journal of Inflammation | Issue 1/2013

Login to get access

Abstract

Background

Obesity and serum C-reactive protein (CRP) (a sensitive marker of inflammatory activity) are associated with most chronic diseases. Abdominal adiposity along with age is the strongest determinant of baseline CRP levels in healthy subjects. The mechanism of the association of serum CRP with disease is uncertain. We hypothesized that baseline serum CRP is a marker of inflammatory responsiveness to injury and that abdominal adiposity is the main determinant of this responsiveness. We studied the effect of abdominal adiposity, age and other environmental risk factors for chronic disease on the CRP response to a standardised surgical insult, unilateral hernia repair to not only test this hypothesis but to inform the factors which must be taken into account when assessing systemic inflammatory responses to surgery.

Methods

102 male subjects aged 24-94 underwent unilateral hernia repair by a single operator. CRP was measured at 0, 6, 24 and 48 hrs. Response was defined as the peak CRP adjusted for baseline CRP.

Results

Age and waist:hip ratio (WHR) were associated both with basal CRP and CRP response with similar effect sizes after adjustment for a wide-range of covariates. The adjusted proportional difference in CRP response per 10% increase in WHR was 1.50 (1.17-1.91) p = 0.0014 and 1.15(1.00-1.31) p = 0.05 per decade increase in age. There was no evidence of important effects of other environmental cardiovascular risk factors on CRP response.

Conclusion

Waist:hip ratio and age need to be considered when studying the inflammatory response to surgery. The finding that age and waist:hip ratio influence baseline and post-operative CRP levels to a similar extent suggests that baseline CRP is a measure of inflammatory responsiveness to casual stimuli and that higher age and obesity modulate the generic excitability of the inflammatory system leading to both higher baseline CRP and higher CRP response to surgery. The mechanism for the association of baseline CRP and waist:hip ratio to chronic disease outcomes could be through this increase in inflammatory system excitability.
Appendix
Available only for authorised users
Literature
1.
go back to reference Seidell JC: Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clinl Nutr. 2010, 64: 35-41.CrossRef Seidell JC: Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clinl Nutr. 2010, 64: 35-41.CrossRef
2.
go back to reference Pischon T, Boeing H, Hoffman K, et al.: General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008, 359: 2105-2120.PubMedCrossRef Pischon T, Boeing H, Hoffman K, et al.: General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008, 359: 2105-2120.PubMedCrossRef
3.
go back to reference Prospective Study Collaboration: Body Mass Index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009, 373: 1083-1096.CrossRef Prospective Study Collaboration: Body Mass Index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009, 373: 1083-1096.CrossRef
4.
go back to reference The Emerging Risk Factors Collaboration: C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: an individual participant meta-analysis. Lancet. 2010, 375: 132-140.PubMedCentralCrossRef The Emerging Risk Factors Collaboration: C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: an individual participant meta-analysis. Lancet. 2010, 375: 132-140.PubMedCentralCrossRef
5.
go back to reference Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996, 312: 1061-1065.PubMedPubMedCentralCrossRef Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996, 312: 1061-1065.PubMedPubMedCentralCrossRef
6.
go back to reference Hermsdorff HH, Zulet MA, Puchau B, Martínez JA: Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011, 34: 161-170.PubMedCrossRef Hermsdorff HH, Zulet MA, Puchau B, Martínez JA: Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011, 34: 161-170.PubMedCrossRef
7.
go back to reference Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011, 29: 415-445.PubMedCrossRef Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011, 29: 415-445.PubMedCrossRef
8.
go back to reference Brooks GC, Blaha MJ, Blumenthal RS: Relation of C-reactive protein to abdominal adiposity. Am J Cardiol. 2010, 106: 56-61.PubMedCrossRef Brooks GC, Blaha MJ, Blumenthal RS: Relation of C-reactive protein to abdominal adiposity. Am J Cardiol. 2010, 106: 56-61.PubMedCrossRef
9.
go back to reference Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J: Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data C reactive protein coronary heart disease genetics collaboration (CCGC). BMJ. 2011, 342: d548-PubMedCrossRef Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J: Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data C reactive protein coronary heart disease genetics collaboration (CCGC). BMJ. 2011, 342: d548-PubMedCrossRef
10.
go back to reference Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE: C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst. 2010, 102: 202-206.PubMedCrossRef Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE: C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst. 2010, 102: 202-206.PubMedCrossRef
11.
go back to reference Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan D, Camm AJ, Northfield TC: Relation of serum levels of cytokines to cardiovascular risk factors and coronary heart disease. Heart. 1997, 78: 273-277.PubMedPubMedCentralCrossRef Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan D, Camm AJ, Northfield TC: Relation of serum levels of cytokines to cardiovascular risk factors and coronary heart disease. Heart. 1997, 78: 273-277.PubMedPubMedCentralCrossRef
12.
go back to reference Berrahmoune H, Herbeth B, Lamont JV, Lambert D, Blankenberg S, Tiret L, FitzGerald PS, Siest G, Visvikis-Siest S: Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort. Clin Chem Lab Med. 2007, 45: 1339-1346.PubMedCrossRef Berrahmoune H, Herbeth B, Lamont JV, Lambert D, Blankenberg S, Tiret L, FitzGerald PS, Siest G, Visvikis-Siest S: Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort. Clin Chem Lab Med. 2007, 45: 1339-1346.PubMedCrossRef
13.
go back to reference Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E: Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care. 2006, 29: 1363-1369.PubMedCrossRef Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E: Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care. 2006, 29: 1363-1369.PubMedCrossRef
14.
go back to reference Libiszewski M, Drozda R, Białecki J, Wieloch M, Hedayati M, Kuzdak K, Kołomecki K: Assesment of inflammatory response intensity in early postoperative period in patients after hernioplasty operated on with classic stoppa method and videoscopic TEP method. Pol Przegl Chir. 2011, 83 (9): 497-501.PubMed Libiszewski M, Drozda R, Białecki J, Wieloch M, Hedayati M, Kuzdak K, Kołomecki K: Assesment of inflammatory response intensity in early postoperative period in patients after hernioplasty operated on with classic stoppa method and videoscopic TEP method. Pol Przegl Chir. 2011, 83 (9): 497-501.PubMed
15.
go back to reference Langenburg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E: Cardiovascular dath and the metabolic syndrome: role of adiposity signalling hormones and inflammatory markers. Diabetes Care. 2006, 29: 1363-1369.CrossRef Langenburg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E: Cardiovascular dath and the metabolic syndrome: role of adiposity signalling hormones and inflammatory markers. Diabetes Care. 2006, 29: 1363-1369.CrossRef
16.
go back to reference Edmonds RD, Cuschieri J, Minei JP, Rosengart MR, Maier RV, Harbrecht BG, Billiar TR, Peitzman AB, Moore EE, Sperry JL: Inflammation the Host Response to Injury Investigators Body adipose content is independently associated with a higher risk of organ failure and nosocomial infection in the nonobese patient postinjury. J Trauma. 2011, 70: 292-298.PubMedCrossRef Edmonds RD, Cuschieri J, Minei JP, Rosengart MR, Maier RV, Harbrecht BG, Billiar TR, Peitzman AB, Moore EE, Sperry JL: Inflammation the Host Response to Injury Investigators Body adipose content is independently associated with a higher risk of organ failure and nosocomial infection in the nonobese patient postinjury. J Trauma. 2011, 70: 292-298.PubMedCrossRef
17.
go back to reference John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-1523.PubMedCrossRef John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-1523.PubMedCrossRef
18.
go back to reference Metcalfe D, Harte AL, Aletrari MO, Al Daghri NM, Al Disi D, Tripathi G, McTernan PG: Does endotoxaemia contribute to osteoarthritis in obese patients?. Clin Sci (Lond). 2012, 123 (11): 627-634.CrossRef Metcalfe D, Harte AL, Aletrari MO, Al Daghri NM, Al Disi D, Tripathi G, McTernan PG: Does endotoxaemia contribute to osteoarthritis in obese patients?. Clin Sci (Lond). 2012, 123 (11): 627-634.CrossRef
Metadata
Title
Abdominal adiposity is the main determinant of the C-reactive response to injury in subjects undergoing inguinal hernia repair
Authors
Sashidhar Irkulla
Bedri Ujam
David Gaze
Devinder Kumar
Michael A Mendall
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2013
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-10-5

Other articles of this Issue 1/2013

Journal of Inflammation 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.